share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Officer Coen Steven P.

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Officer Coen Steven P.

Ginkgo Bioworks | 4:持股變動聲明-高管 Coen Steven P.
美股sec公告 ·  06/06 05:12
牛牛AI助理已提取核心訊息
Steven P. Coen, associated with Ginkgo Bioworks Holdings, Inc. (trading symbol DNA), completed a series of transactions involving the company's Class A Common Stock. On May 31, 2024, Coen acquired a total of 29,745 shares through the exercise or conversion of derivative securities, at no reported transaction price. Subsequently, on June 3, 2024, Coen sold 13,440 shares in an open market transaction at a price of $0.549 per share, totaling a market value of $7,378.56. After these transactions, Coen's direct holdings in Ginkgo Bioworks amounted to 178,832 shares of Class A Common Stock.
Steven P. Coen, associated with Ginkgo Bioworks Holdings, Inc. (trading symbol DNA), completed a series of transactions involving the company's Class A Common Stock. On May 31, 2024, Coen acquired a total of 29,745 shares through the exercise or conversion of derivative securities, at no reported transaction price. Subsequently, on June 3, 2024, Coen sold 13,440 shares in an open market transaction at a price of $0.549 per share, totaling a market value of $7,378.56. After these transactions, Coen's direct holdings in Ginkgo Bioworks amounted to 178,832 shares of Class A Common Stock.
與Ginkgo Bioworks Holdings, Inc.(交易代號DNA)相關的Steven P. Coen完成一系列的交易,涉及公司的A類普通股。2024年5月31日,Coen通過行使或轉換衍生證券總共取得29,745股,並沒有報告的交易價格。隨後,於2024年6月3日,Coen以每股0.549美元的價格在公開市場交易中賣出13,440股,總市值為7,378.56美元。這些交易後,Coen在Ginkgo Bioworks的直接持股總共有178,832股A類普通股。
與Ginkgo Bioworks Holdings, Inc.(交易代號DNA)相關的Steven P. Coen完成一系列的交易,涉及公司的A類普通股。2024年5月31日,Coen通過行使或轉換衍生證券總共取得29,745股,並沒有報告的交易價格。隨後,於2024年6月3日,Coen以每股0.549美元的價格在公開市場交易中賣出13,440股,總市值為7,378.56美元。這些交易後,Coen在Ginkgo Bioworks的直接持股總共有178,832股A類普通股。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。